Officer - Verizon Keynote at Leading Pharmaceutical Communication Event
Where Executives Gather to Discuss Pressing Issues - The 4th Annual PR &
Communications Summit for Pharmaceutical, Biotech and Medical Technology
Companies
NEW YORK, May 29 /PRNewswire/ -- ExL Pharma (http://www.exlpharma.com)
is pleased to announce the participation of two keynote speakers from the
U.S. Food and Drug Administration and Verizon during the 4th Annual Public
Relations and Communications Summit: The Leading Event for Pharmaceutical,
Biotech and Medical Technology Corporate and Brand Communicators taking
place on July 14-15, 2008 at the Heldrich Conference Center in New
Brunswick, N.J. (http://www.exlpharma.com/eventDetail.php?id=112) Susan
Winckler, Chief of Staff at the FDA will share an update on improving
communication issues with the FDA. This presentation is much anticipated as
a result of ongoing press on the relationship between the agency and
industry. Also confirmed to speak is Peter Thonis, Chief Communications
Officer with Verizon. Mr. Thonis is going to lend his insight to the
pharmaceutical executives in attendance on communicating with key
stakeholders and keeping customers, an area that Verizon has had much
success.
The 4th Annual Public Relations and Communications Summit
(http://www.exlpharma.com/eventDetail.php?id=112) event brings together
communication executives, press and agencies to discuss best practices and
challenges relating to corporate, brand and internal communication
strategies. Now in its 4th year, this premier event has grown to become the
industry standard for senior executives seeking educational and networking
opportunities in this field.
Additional program highlights include the number of industry case
studies around key issues and challenges that our industry is currently
facing. Topics that will be discussed include: new media tools,
communicating more effectively with press, internal communications,
handling a crisis, the ongoing reputation challenge, DTC advertising, key
policy and legislative issues, ROI measurement, corporate social
responsibility, agency/client relations, advocacy relations, marketing & PR
collaboration, global PR, and much more.
Speakers include senior representatives from many of the leading
pharmaceutical, biotech and medical technology companies such as: Abbott,
BD, Centocor, Cephalon, Gilead, Genentech, Merck, Novartis, Pfizer,
sanofi-aventis, Schering-Plough, Teva, Wyeth Pharmaceuticals and more.
This premier event is co-sponsored by DS Simon, Fleishman Hillard,
Manning Salvage & Lee, MCS Public Relations, MultiVu, Ketchum, Healthstar
PR, Medialink, Cision, Vocus, NAPS, & Cohn & Wolfe.
By attending this event, you will have the rare opportunity to
networking with highly regarded communication executives from this
industry, leading agency executives and key press/media such as the Wall
Street Journal.
To maximize your company's exposure and take advantage of senior-level
networking opportunities through sponsorship and exhibiting, please
contact: Bryon Main, at bmain@exlpharma.com or by phone at 212-400-6246
To view the full program agenda and full roster of our expert speaking
faculty and to REGISTER*
Log onto: http://www.exlpharma.com
* When registering, provide Registration and Priority Code: P218PR1
EARLY REGISTRATION RATES EXPIRE TOMORROW -MAY 30TH- REGISTER NOW AND SAVE
About ExL
ExL Pharma, a division of ExL Events, Inc., is an international leader
in developing innovative, educational events that serve the healthcare
community and allied professionals. Behind our diverse conference
portfolio, our experienced team conducts extensive market research and
targeted outreach. The results translate into innovative, high-quality
conference events designed to exceed the dynamic informational needs of the
healthcare community.
SOURCE ExL Pharma
 back to top
Related links:
http://www.exlpharma.com
http://www.exlpharma.com/eventDetail.php?id=112
CONTACT:
Bryon Main of ExL Pharma, +1-212-400-6246,
bmain@exlpharma.com
|
